Alpa Laboratories Limited (BOM:532878)
59.00
-0.09 (-0.15%)
At close: Oct 6, 2026
Alpa Laboratories Revenue
Alpa Laboratories had revenue of 239.31M INR in the quarter ending June 30, 2026, with 25.22% growth. This brings the company's revenue in the last twelve months to 1.11B, up 0.46% year-over-year. In the fiscal year ending March 31, 2026, Alpa Laboratories had annual revenue of 1.06B, down -5.91%.
Revenue (ttm)
1.11B
Revenue Growth
+0.46%
P/S Ratio
1.10
Revenue / Employee
2.42M
Employees
457
Market Cap
1.21B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.06B | -66.42M | -5.91% |
| Mar 31, 2025 | 1.12B | 37.13M | 3.41% |
| Mar 31, 2024 | 1.09B | 157.84M | 16.98% |
| Mar 31, 2023 | 929.55M | -193.11M | -17.20% |
| Mar 31, 2022 | 1.12B | 147.12M | 15.08% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Parnax Lab | 2.52B |
| Lactose (India) | 1.71B |
| Aayush Wellness | 1.66B |
| Makers Laboratories | 1.49B |
| Godavari Drugs | 1.11B |
| Concord Drugs | 860.69M |
| Speciality Medicines | 752.85M |
| Asston Pharmaceuticals | 254.69M |